Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19.

Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19. Med Hypotheses. 2021 01; 146:110380.

View in: PubMed